InsidersTradesSigma
Track the 株式会社サイトリ細胞研究所 stock price and the full directors' dealings record of the company, a listed equity based in Japan. Shares are quoted on the JP market, under the authority of EDINET (Japan FSA). Operating in the Health Care sector, 株式会社サイトリ細胞研究所 has published 4 reports. The latest transaction was disclosed on 23 June 2023 (Holding update). Among the most active insiders: HG Capital Co.,Ltd.. The full history is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
4 of 4 declarations
株式会社サイトリ細胞研究所 is a company focused on cellular research, dedicated to developing innovative therapies. It primarily operates in the health and pharmaceutical sector.